Jean-Christophe Leroux received his B.Pharm. from the University of Montreal, followed by a Ph.D. in Pharmaceutical Sciences from the University of Geneva. From 1996 to 1997 he completed a postdoctoral training at the University of California, San Francisco and then joined the University of Montreal as an assistant professor. He was promoted to the ranks of associate professor in 2002 and full professor in 2007.
In 2001, he was awarded the Canada Research Chair in Drug Delivery. Prof. Leroux joined the Institute of Pharmaceutical Sciences at ETH Zurich as ordinary professor at the end of 2008, and was head of the institute from 2014 to 2016. His research interests include the design of novel biomaterials and drug delivery systems, and the evaluation of colloidal antidotes for the treatment of toxicosis.
He is the author or coauthor of more than 215 refereed articles (h-index: 72), 14 book chapters and 22 patents/patent applications. He serves in the editorial board of the Journal of Controlled Release, Molecular Pharmaceutics, Biomacromolecules, and the Journal of Drug Delivery Science and Technology. He has received several prestigious distinctions such as the CRS Young Investigator Award (2004), the Debiopharm Life Sciences Award (2010), the APV Research Award (2014) and the Phoenix award (2015) for his innovative research in pharmaceutical technology.
He is a fellow of the Controlled Release Society and the co-founder of Versantis AG and Inositec AG.